Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ·Healthcare·Biotechnology
$94.06
+0.03%
Mkt Cap $4.59B
Analyst Ratings
Buy
17
Hold
0
Sell
0
Price Target (35 analysts)
$116.70
Range $95.00 – $140.00
Implied Upside
+24.1%
Consensus $116.70 vs current $94.06
NASDAQ·Healthcare·Biotechnology
$94.06
+0.03%
Mkt Cap $4.59B
Buy
17
Hold
0
Sell
0
Price Target (35 analysts)
$116.70
Range $95.00 – $140.00
+24.1%
Consensus $116.70 vs current $94.06